Key result
Tumour grade and metastasis were significant independent prognostic factors for survival in patients with myxofibrosarcoma (p=0.041 and p=0.00007, respectively).
Why the study?
The study aimed to evaluate prognostic factors affecting survival in patients with myxofibrosarcoma.
What are the prognostic factors affecting survival in patients with myxofibrosarcoma?
Population
34 patients with myxofibrosarcoma
Comparison
Prognostic clinical, pathological, and laboratory factors
Design
Retrospective single-centre analysis
Follow-up
Minimum follow-up period of 60 months (range=60-156 months)
Authors
Loading...
May inform risk stratification in myxofibrosarcoma; leaves open optimal management for high-risk patients.
Cohort (n=34)
No
What are the prognostic factors affecting survival in patients with myxofibrosarcoma?
p-value: p=0.041 and 0.00007
Tumour grade and metastasis are independent prognostic factors for disease-specific survival in patients with myxofibrosarcoma.
Mühlhofer et al. (2019) conducted a cohort in Myxofibrosarcoma (n=34). Tumour grade and metastasis was evaluated on Survival (p=0.041 and 0.00007). Tumour grade and metastasis were significant independent prognostic factors for survival in patients with myxofibrosarcoma (p=0.041 and p=0.00007, respectively).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: